Profil
Lori Friedman is currently Director at NextRNA Therapeutics, Inc. since 2023.
Director at Project Scientist since 2018.
Chief Scientific Officer at Oric Pharmaceuticals, Inc. since 2019.
Formerly Independent Director at Jiya Acquisition Corp.
Head-Translational Oncology at Genentech, Inc. Earned a doctorate from the University of California, Berkeley.
Aktiva positioner av Lori Friedman
| Företag | Position | Start |
|---|---|---|
| ORIC PHARMACEUTICALS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2019-07-01 |
Project Scientist
Project Scientist Investment Trusts/Mutual FundsMiscellaneous Operates as an education nonprofit organization | Direktör/Styrelseledamot | 2018-05-01 |
NextRNA Therapeutics, Inc.
NextRNA Therapeutics, Inc. BiotechnologyHealth Technology Engages in biotechnology and drug development services | Direktör/Styrelseledamot | 2023-09-26 |
Tidigare kända positioner av Lori Friedman
| Företag | Position | Slut |
|---|---|---|
| JIYA ACQUISITION CORP. | Direktör/Styrelseledamot | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Företagsledare/Principal | - |
Lori Friedmans utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 6 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oric Pharmaceuticals, Inc.
Oric Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops pharmaceutical products | Health Technology |
Project Scientist
Project Scientist Investment Trusts/Mutual FundsMiscellaneous Operates as an education nonprofit organization | Miscellaneous |
Jiya Acquisition Corp.
Jiya Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
NextRNA Therapeutics, Inc.
NextRNA Therapeutics, Inc. BiotechnologyHealth Technology Engages in biotechnology and drug development services | Health Technology |
















